Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ramani Durvasula & Theodore R. Miller. (2014) Substance Abuse Treatment in Persons with HIV/AIDS: Challenges in Managing Triple Diagnosis. Behavioral Medicine 40:2, pages 43-52.
Read now
Read now
I.
Julian Osuji, Elizabeth Tucker & E.
Sherwood Brown. (2008) Declarative Memory in Patients With Bipolar Disorder and Stimulant Abuse Receiving Lamotrigine. Journal of Dual Diagnosis 4:3, pages 303-313.
Read now
Read now
Lynn C. Winther, Rehan Saleem, Elinore F. McCance-Katz, Marc I. Rosen, Faiq A. Hameedi, H. Rowland Pearsall, Peter I. Jatlow, Thomas R. Kosten & Scott W. Woods. (2000) Effects of Lamotrigine on Behavioral and Cardiovascular Responses to Cocaine in Human Subjects. The American Journal of Drug and Alcohol Abuse 26:1, pages 47-59.
Read now
Read now
Articles from other publishers (25)
Josh E. Becker, Julianne L. Price, David Leonard, Alina Suris, Enas Kandil, Meredith Shaw, Sven Kroener, E Sherwood Brown & Bryon Adinoff. (2020) The Efficacy of Lidocaine in Disrupting Cocaine Cue-Induced Memory Reconsolidation. Drug and Alcohol Dependence 212, pages 108062.
Crossref
Crossref
Mei-Yi Lee, Yu-Ching Hsiao, Ming-Huan Chan & Hwei-Hsien Chen. (2019) Lamotrigine attenuates the motivation to self-administer ketamine and prevents cue- and prime-induced reinstatement of ketamine-seeking behavior in rats. Drug and Alcohol Dependence 194, pages 257-263.
Crossref
Crossref
Stacy M. Ku & Ming-Hu Han. (2017) HCN Channel Targets for Novel Antidepressant Treatment. Neurotherapeutics 14:3, pages 698-715.
Crossref
Crossref
Ming-Chyi Huang, Lian-Yu Chen, Chih-Ken Chen & Shih-Ku Lin. (2016) Potential benefit of lamotrigine in managing ketamine use disorder. Medical Hypotheses 87, pages 97-100.
Crossref
Crossref
Jadwiga Zalewska-Kaszubska, Bartosz Bajer, Dorota Gorska, Dariusz Andrzejczak, Wanda Dyr & Przemysław Bieńkowski. (2015) Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with lamotrigine. Physiology & Behavior 139, pages 7-12.
Crossref
Crossref
Magdalena Chrościńska-Krawczyk, Magdalena Wałek, Bożydar Tylus & Stanisław J. Czuczwar. (2014) Selected classical and novel antiepileptic drugs - mechanisms of action, neuroprotection, and effectiveness in epileptic and non-epileptic conditions. Journal of Epileptology 22:1, pages 37-50.
Crossref
Crossref
E Sherwood Brown, Prabha Sunderajan, Lisa T Hu, Sharon M Sowell & Thomas J Carmody. (2012) A Randomized, Double-Blind, Placebo-Controlled, Trial of Lamotrigine Therapy in Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence. Neuropsychopharmacology 37:11, pages 2347-2354.
Crossref
Crossref
Icro Maremmani, Fabio Rugani, Luca Rovai, Angelo Giovanni Icro Maremmani, Francesco Lamanna, Barbara Capovani, Matteo Pacini & Liliana dell'Osso. (2012) Long-term Usefulness of Cabergoline to Patients in Refraining From Cocaine Use After Detoxification. Addictive Disorders & Their Treatment 11:1, pages 1-5.
Crossref
Crossref
M. Foster Olive, Richard M. Cleva, Peter W. Kalivas & Robert J. Malcolm. (2012) Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacology Biochemistry and Behavior 100:4, pages 801-810.
Crossref
Crossref
Heath D. Schmidt & R. Christopher Pierce. (2010) Cocaine-induced neuroadaptations in glutamate transmission. Annals of the New York Academy of Sciences 1187:1, pages 35-75.
Crossref
Crossref
Icro Maremmani, Matteo Pacini, Francesco Lamanna, Pier Paolo Pani, Giulio Perugi, Joseph Deltito, Ihsan M. Salloum & Hagop Akiskal. (2014) Mood Stabilizers in the Treatment of Substance Use Disorders. CNS Spectrums 15:2, pages 95-109.
Crossref
Crossref
Bianca Jupp & Andrew J. Lawrence. (2010) New horizons for therapeutics in drug and alcohol abuse. Pharmacology & Therapeutics 125:1, pages 138-168.
Crossref
Crossref
E Sherwood Brown, Justin Wolfshohl, Mujeeb U Shad, Miguel Vazquez & I Julian Osuji. (2007) Attenuation of the Effects of Corticosteroids on Declarative Memory with Lamotrigine. Neuropsychopharmacology 33:10, pages 2376-2383.
Crossref
Crossref
Justin T. Gass & M. Foster Olive. (2008) Glutamatergic substrates of drug addiction and alcoholism. Biochemical Pharmacology 75:1, pages 218-265.
Crossref
Crossref
Valentina Vengeliene, Christian A. Heidbreder & Rainer Spanagel. (2007) The effects of lamotrigine on alcohol seeking and relapse. Neuropharmacology 53:8, pages 951-957.
Crossref
Crossref
Sharron Dawes & Igor Grant. 2007. HIV/AIDS and the Nervous System. HIV/AIDS and the Nervous System
93
121
.
E. Sherwood Brown, Dana C. Perantie, Nafisa Dhanani, Laura Beard, Paul Orsulak & A. John Rush. (2006) Lamotrigine for bipolar disorder and comorbid cocaine dependence: A replication and extension study. Journal of Affective Disorders 93:1-3, pages 219-222.
Crossref
Crossref
S. Paul Berger, Theresa M. Winhusen, Eugene C. Somoza, Judy M. Harrer, Juris P. Mezinskis, Deborah B. Leiderman, Margaret A. Montgomery, R. Jeffrey Goldsmith, Daniel A. Bloch, Bonita M. Singal & Ahmed Elkashef. (2005) A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 100, pages 58-67.
Crossref
Crossref
Alvaro Camacho & Hagop S. Akiskal. (2005) Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers. Journal of Affective Disorders 85:1-2, pages 217-230.
Crossref
Crossref
E. Sherwood Brown, Alan Frol, Leonardo Bobadilla, Vicki A. Nejtek, Dana C. Perantie & Harminder Dhillon. (2003) Effect of Lamotrigine on Mood and Cognition in Patients Receiving Chronic Exogenous Corticosteroids. Psychosomatics 44:3, pages 204-208.
Crossref
Crossref
James A. Halikas, Bruce A. Center, Victoria L. Pearson, Gregory A. Carlson & Fredrick Crea. (2001) A pilot, open clinical study of depakote in the treatment of cocaine abuse. Human Psychopharmacology: Clinical and Experimental 16:3, pages 257-264.
Crossref
Crossref
CHRISTOPHER J. WELSH & JOSEPH LIBERTO. (2001) The Use of Medication for Relapse Prevention in Substance Dependence Disorders. Journal of Psychiatric Practice 7:1, pages 15-31.
Crossref
Crossref
KEVIN A. SEVARINO, ALISON OLIVETO & THOMAS R. KOSTEN. (2006) Neurobiological Adaptations to Psychostimulants and Opiates as a Basis of Treatment Development. Annals of the New York Academy of Sciences 909:1, pages 51-87.
Crossref
Crossref
Raymond G. Schlienger, Lori E. Shapiro & Neil H. Shear. (1998) Lamotrighe-Induced Severe Cutaneous Adverse Reactions. Epilepsia 39:s7, pages S22-S26.
Crossref
Crossref
S.Kelly Avants, Arthur Margolin, Thomas J. McMahon & Thomas R. Kosten. (1997) Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients. Addictive Behaviors 22:5, pages 599-611.
Crossref
Crossref